Detail akcie Twist Bioscience Rg online

Business Summary: Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
Financial Summary: BRIEF: For the six months ended 31 March 2025, Twist Bioscience Corp revenues increased 24% to $181.5M. Net loss decreased 20% to $70.9M. Revenues reflect NGS tools segment increase of 24% to $99.8M, Synthetic genes segment increase of 30% to $54.7M, Americas segment increase of 21% to $108.9M, EMEA segment increase of 36% to $58.9M. Lower net loss reflects Research and development - Balancing decrease of 5% to $39M (expense).